Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure
Titel:
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure
Auteur:
Wang, Michael Dimopoulos, Meletios A. Chen, Christine Cibeira, M. Teresa Attal, Michel Spencer, Andrew Rajkumar, S. Vincent Yu, Zhinuan Olesnyckyj, Marta Zeldis, Jerome B. Knight, Robert D. Weber, Donna M.